Plain-English translation of NCT07301034 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called to see if it can help reduce plaque buildup in the arteries of the heart after you've had a heart attack. You would receive either the medication or a placebo (a dummy treatment with no active ingredient), along with your standard heart care. The study will last about 15 months and involve monthly injections.
After a heart attack, plaque can build up again in your heart arteries and cause future problems. This medication hasn't been approved yet, so doctors need to study whether this treatment can help prevent that buildup and protect your heart better than standard care alone.
You likely qualify if…
You likely don't qualify if…
If you join, you'll receive either the new medication or a placebo as a monthly injection under your skin for 12 months, along with your regular heart medications. You'll also need to come back for special heart imaging scans at the beginning and end of the study to let doctors see if the treatment is working. The entire study lasts about 15 months, and you'll have regular follow-up visits to check how you're doing.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Austria
Denmark
Italy